Collectively, these results demonstrated that knocking out GPT2 leads to significant metabolic rewiring in cisplatin-resistant ovarian cancer cells, ultimately favoring resensitization to cisplatin treatment. This evidence concerns the gene GPT2 and ovarian carcinoma.